Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Interaction of α-synuclein with biomembranes in Parkinson's disease--role of cardiolipin

Ghio S, Kamp F, Cauchi R, Giese A, Vassallo N.

Prog Lipid Res. 2016 Jan;61:73-82. doi: 10.1016/j.plipres.2015.10.005. Epub 2015 Dec 15.

Development of Passive Immunotherapies for Synucleinopathies

Bergström AL, Kallunki P, Fog K.

Mov Disord. 2016 Feb;31(2):203-13. doi: 10.1002/mds.26481. Epub 2015 Dec 25.

Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases

Nakamura T, Lipton SA.

Trends Pharmacol Sci. 2016 Jan;37(1):73-84. doi: 10.1016/j.tips.2015.10.002. Epub 2015 Dec 17.

Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease

Litim N, Morissette M, Di Paolo T.

Neurosci Biobehav Rev. 2016 Aug;67:79-88. doi: 10.1016/j.neubiorev.2015.09.024. Epub 2015 Dec 17.

Microglia-blood vessel interactions: a double-edged sword in brain pathologies

Dudvarski Stankovic N, Teodorczyk M, Ploen R, Zipp F, Schmidt MHH.

Acta Neuropathol. 2016 Mar;131(3):347-63. doi: 10.1007/s00401-015-1524-y. Epub 2015 Dec 28.

The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease

Reynolds GO, Otto MW, Ellis TD, Cronin-Golomb A.

Mov Disord. 2016 Jan;31(1):23-38. doi: 10.1002/mds.26484. Epub 2015 Dec 30.

Multiple re-challenges for clozapine neutropenia in Parkinson's disease

Komaragiri A, Friedman JH.

Parkinsonism Relat Disord. 2016 Feb;23:114-5. doi: 10.1016/j.parkreldis.2015.12.009. Epub 2015 Dec 17.

Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies

Zhang Y, Chen J, Qiu J, Li Y, Wang J, Jiao J.

Am J Clin Nutr. 2016 Feb;103(2):330-40. doi: 10.3945/ajcn.115.124081. Epub 2015 Dec 30.

Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyond

Calderón-Garcidueñas L, Leray E, Heydarpour P, Torres-Jardón R, Reis J.

Rev Neurol (Paris). 2016 Jan;172(1):69-80. doi: 10.1016/j.neurol.2015.10.008. Epub 2015 Dec 21.

Epidemiology of Parkinson's disease

Elbaz A, Carcaillon L, Kab S, Moisan F.

Rev Neurol (Paris). 2016 Jan;172(1):14-26. doi: 10.1016/j.neurol.2015.09.012. Epub 2015 Dec 21.

Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra

Aumann TD.

J Chem Neuroanat. 2016 Apr;73:21-32. doi: 10.1016/j.jchemneu.2015.12.009. Epub 2015 Dec 21.

Endocytic membrane trafficking and neurodegenerative disease

Schreij AM, Fon EA, McPherson PS.

Cell Mol Life Sci. 2016 Apr;73(8):1529-45. doi: 10.1007/s00018-015-2105-x. Epub 2015 Dec 31.

Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs

Caccamo D, Pisani LR, Mazzocchetti P, Ientile R, Calabresi P, Pisani F, Costa C.

Neurochem Res. 2016 Feb;41(1-2):340-52. doi: 10.1007/s11064-015-1809-5. Epub 2015 Dec 31.

The Most Cited Works in Aneurysmal Subarachnoid Hemorrhage: A Bibliometric Analysis of the 100 Most Cited Articles

Alotaibi NM, Nassiri F, Badhiwala JH, Witiw CD, Ibrahim GM, Macdonald RL, Lozano AM.

World Neurosurg. 2016 May;89:587-592.e6. doi: 10.1016/j.wneu.2015.11.072. Epub 2015 Dec 23.

Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly

Luo SX, Huang EJ.

Am J Pathol. 2016 Mar;186(3):478-88. doi: 10.1016/j.ajpath.2015.09.023. Epub 2015 Dec 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias